13F filer · CIK 1274413
SECTORAL ASSET MANAGEMENT INC
MONTREAL, A8 · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$143.3M
+$22.6M vs prior
Positions
82
New / sold out
15 / 10
Added / reduced
17 / 17
Turnover
19.3%
buys $40.6M · sells $25.5M
Top-10 weight
39.6%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | ORUKA THERAPEUTICS INC | +41,987 | – | +$4.0M |
| New | DEFINIUM THERAPEUTICS INC | +78,310 | – | +$3.7M |
| New | IRHYTHM HOLDINGS INC | +26,070 | – | +$3.1M |
| New | AVALO THERAPEUTICS INC | +119,923 | – | +$2.2M |
| Added | SUMMIT THERAPEUTICS | +150,565 | +216.3% | +$2.2M |
| New | CRESCENT BIOPHARMA INC. | +121,300 | – | +$2.2M |
| Added | ARCUS BIOSCIENCES | +65,800 | +146.0% | +$2.0M |
| New | PULSE BIOSCIENCES INC | +67,895 | – | +$1.9M |
| Added | DEXCOM INC | +27,525 | +118.5% | +$1.9M |
| Added | BIONTECH SE | +19,705 | +88.9% | +$1.8M |
22 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | EVOMMUNE INC | -589,005 | -100.0% | $-13.5M |
| Reduced | GILEAD SCIENCES INC | -6,870 | -25.0% | $-868.0K |
| Sold out | RAPPORT THERAPEUTICS | -25,421 | -100.0% | $-835.0K |
| Reduced | VERTEX PHARMA | -1,575 | -22.5% | $-782.3K |
| Sold out | BOUNDLESS BIO | -678,574 | -100.0% | $-746.4K |
| Sold out | ASCENDIS PHARMA A S | -2,800 | -100.0% | $-728.3K |
| Reduced | UNITEDHEALTH GRP INC | -1,722 | -11.5% | $-715.7K |
| Reduced | ABBOTT LABS | -7,498 | -29.3% | $-680.4K |
| Reduced | ARGENX SE | -733 | -20.6% | $-680.1K |
| Reduced | STRUCTURE THERAPEUTICS | -9,777 | -69.3% | $-524.7K |
17 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | CONTINEUM THERAPEUTICSCL A | 727,587 | $11.9M | 8.32% |
| 2 | SHOULDER INNOVATIONSCOMMON STOCK | 430,407 | $8.7M | 6.09% |
| 3 | LLYELI LILLY & CO | 6,354 | $7.6M | 5.32% |
| 4 | UNITEDHEALTH GRP INCCOM | 13,235 | $5.5M | 3.84% |
| 5 | JNJJOHNSON & JOHNSON | 18,218 | $4.6M | 3.23% |
| 6 | ORUKA THERAPEUTICS INCCOM | 41,987 | $4.0M | 2.79% |
| 7 | BIONTECH SESP ADR | 41,869 | $3.9M | 2.72% |
| 8 | DEFINIUM THERAPEUTICS INCCOM SHS | 78,310 | $3.7M | 2.57% |
| 9 | DEXCOM INCCOM | 50,756 | $3.4M | 2.39% |
| 10 | ARCUS BIOSCIENCESCOM | 110,870 | $3.4M | 2.39% |
72 more rows. Subscribe for $29/month to see every row, download the data and use the API.